Organism name | Pseudotsuga wilsoniana |
---|---|
Genus | Pseudotsuga |
Family | Pinaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Pseudotsuga sinensis var. wilsoniana |
---|---|
Linked NCBI taxonomy ID | 71408 |
Linked level | varietas |
Family in NCBI taxonomy | Pinaceae |
---|---|
ID | 3318 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Spermatophyta |
---|---|
ID | 58024 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00000982
![]() |
Naringenin
/ (-)-Naringenin |
CHEMBL9352
CHEMBL32571 |
C005273
|
57 / 46 / 40 | 35 / 10 | No. 25 | No. 14 |
![]() |
C00000992
![]() |
Pinocembrin
|
CHEMBL70518
CHEMBL399910 CHEMBL399249 |
C016063
|
18 / 23 / 23 | 5 / 0 | No. 25 | No. 14 |
![]() |
C00001006
![]() |
Strobopinin
|
CHEMBL227611
CHEMBL1556958 |
12 / 5 / 3 | No. 25 | No. 14 |
![]() |
||
C00014147
![]() |
(2R)-5,4'-Dihydroxy-7-methoxy-6-methylflavanone
|
No. 25 | No. 14 |
![]() |
||||
C00008237
![]() |
Poriol
|
CHEMBL484640
|
20 / 14 / 14 | No. 25 | No. 14 |
![]() |
||
C00003672
![]() |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00029821
![]() |
Sitostenone
/ beta-Sitostenone / Stigmast-4-en-3-one / Stigmast-4-ene-3-one |
CHEMBL66926
|
No. 53 | No. 11 |
![]() |
|||
C00003794
![]() |
Chrysin
/ 5,7-Dihydroxyflavone / 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one |
CHEMBL117
|
C043561
|
100 / 89 / 87 | 69 / 6 | No. 76 | No. 15 |
![]() |
C00020065
![]() |
alpha-Cadinol
/ (-)-alpha-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00031283
![]() |
Sandaracopimaric acid
/ (-)-Sandaracopimaric acid |
CHEMBL513197
CHEMBL1397211 CHEMBL1410398 CHEMBL1735595 |
C082072
|
14 / 13 / 7 | No. 208 | No. 48 |
![]() |
|
C00042455
![]() |
Dehydroabietic acid
|
CHEMBL12850
|
C013913
|
No. 323 | No. 41 |
![]() |
||
C00034167
![]() |
Pomiferin A
/ (+)-Pomiferin A / 18-Hydroxy-dehydroabietane |
CHEMBL12799
|
No. 359 | No. 40 |
![]() |
|||
C00042729
![]() |
Meridinol
|
No. 629 | No. 21 |
![]() |
||||
C00003028
![]() |
Borneol
/ (+/-)-Borneol |
CHEMBL296404
CHEMBL486208 CHEMBL1097205 CHEMBL1968981 |
8 / 5 / 1 | No. 649 | No. 35 |
![]() |
||
C00003166
![]() |
Nerolidol
|
CHEMBL25424
CHEMBL508801 CHEMBL561014 CHEMBL1923157 |
3 / 3 / 1 | No. 726 | No. 38 |
![]() |
||
C00002683
![]() |
Vanillin
|
CHEMBL13883
|
18 / 8 / 9 | No. 1003 |
![]() |
|||
C00048973
![]() |
Epijuvabione
/ (+)-Epijuvabione |
No. 2112 | No. 38 |
![]() |
||||
C00048972
![]() |
Epijuvabiol
|
No. 2112 | No. 38 |
![]() |
||||
C00049001
![]() |
Methyl 15-hydroxydehydroabietate
|
No. 2322 |
![]() |
|||||
C00048957
![]() |
Atlantolone
|
No. 3871 |
![]() |
|||||
C00049003
![]() |
Methyl atlantonate
|
No. 4194 | No. 38 |
![]() |
||||
C00048953
![]() |
9-Oxo-bis-abola-1,3,5,7E-tetraen-15-oic acid methyl ester
|
No. 7906 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000982 C00000992 C00003672 C00003794 C00031283 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000982 C00000992 C00003672 C00003794 C00031283 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000982 C00000992 C00003672 C00003794 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000982 C00000992 C00003672 C00003794 | 1 / 0 |
O75496 | Geminin | Unclassified protein | C00000982 C00001006 C00003794 C00031283 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000982 C00000992 C00003794 C00008237 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00000982 C00000992 C00003794 C00008237 | 2 / 5 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000992 C00003794 C00008237 C00031283 | 7 / 3 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000982 C00000992 C00003672 C00003794 | 0 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000982 C00002683 C00003672 | 1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001006 C00003794 C00031283 | 2 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000982 C00002683 C00003794 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000982 C00002683 C00003794 | 3 / 4 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002683 C00003794 C00031283 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000982 C00003028 C00003794 | 3 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000982 C00000992 C00003794 | 3 / 3 |
P06746 | DNA polymerase beta | Enzyme | C00001006 C00003672 C00008237 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00000982 C00001006 C00003794 | 2 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000982 C00003028 C00003794 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00000992 C00008237 C00031283 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000982 C00003028 C00003794 | 5 / 1 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000982 C00003028 C00003794 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00000992 C00003672 C00003794 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000992 C00001006 C00008237 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00000982 C00003672 C00003794 | 1 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00000982 C00000992 C00003794 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000982 C00003672 C00003794 | 1 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000982 C00001006 C00008237 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000982 C00001006 C00003794 | 0 / 3 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00000982 C00000992 C00003794 | 4 / 4 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00000982 C00003794 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002683 C00003794 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00000992 C00003794 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00008237 C00031283 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000982 C00003794 | 1 / 1 |
P62158 | Calmodulin | Unclassified protein | C00000982 C00003794 | 1 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002683 C00003028 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00003794 C00031283 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00003794 C00031283 | 1 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000982 C00003794 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000992 C00031283 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002683 C00003794 | 2 / 2 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00000982 C00003794 | 1 / 1 |
O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | C00000982 C00003794 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000992 C00003794 | 4 / 3 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002683 C00003028 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00000982 C00003794 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00003794 C00008237 | 2 / 3 |
Q96RI1 | Bile acid receptor | NR1H4 | C00002683 C00003794 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00000982 C00003794 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00000982 C00003794 | 5 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002683 C00003794 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 C00003794 | 4 / 2 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00000982 C00003794 | 2 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000982 C00003794 | 0 / 1 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00000982 C00003794 | 1 / 1 |
P15121 | Aldose reductase | Enzyme | C00000982 C00003794 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000992 C00001006 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00008237 C00031283 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001006 C00031283 | 1 / 0 |
P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00000982 C00003794 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000982 C00003672 | 0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00000982 C00003794 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002683 C00003028 | 0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00002683 C00003794 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00000982 C00003794 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00003794 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000982 C00003166 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000982 | 0 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00003794 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000982 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00003794 | 4 / 2 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00031283 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001006 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00008237 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00008237 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003794 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00000982 | 1 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00001006 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00003794 | 0 / 0 |
P51843 | Nuclear receptor subfamily 0 group B member 1 | Nuclear hormone receptor subfamily 0 group B member 1 | C00003794 | 2 / 2 |
P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
P04278 | Sex hormone-binding globulin | Secreted protein | C00000982 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00003794 | 1 / 2 |
P16581 | E-selectin | Adhesion | C00003794 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00003794 | 0 / 0 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002683 | 1 / 1 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000982 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00000982 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00000982 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001006 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00003794 | 0 / 0 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00008237 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00003794 | 0 / 1 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00002683 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00008237 | 1 / 0 |
P24864 | G1/S-specific cyclin-E1 | Other cytosolic protein | C00000982 | 0 / 2 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00003794 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00000982 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00003794 | 0 / 0 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00003028 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000982 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00003794 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000982 | 1 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000982 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003794 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00003166 | 0 / 0 |
P14151 | L-selectin | Adhesion | C00003794 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00003794 | 1 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002683 | 0 / 0 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00003794 | 1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00003794 | 1 / 2 |
P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002683 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00003166 | 3 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | C00003794 | 1 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00000982 | 6 / 4 |
P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | C00002683 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00003794 | 1 / 1 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000982 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00003794 | 0 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00008237 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00003794 | 0 / 0 |
P49888 | Estrogen sulfotransferase | Enzyme | C00000982 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00008237 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00003794 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00008237 | 0 / 0 |
P56937 | 3-keto-steroid reductase | Enzyme | C00003794 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00000982 | 1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00003794 | 4 / 1 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00008237 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003794 | 7 / 37 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00003794 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00003794 | 1 / 0 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00003794 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00003794 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00003794 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00003794 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00003794 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00003794 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00003794 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00003794 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00003794 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00003794 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00003794 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00003794 | 1 / 0 |
Q02410 | Amyloid beta A4 precursor protein-binding family A member 1 | Unclassified protein | C00008237 | 0 / 0 |
Q00975 | Voltage-dependent N-type calcium channel subunit alpha-1B | N-TYPE | C00008237 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00003794 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00003794 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00003794 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00003794 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00003794 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00003794 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00003794 | 1 / 1 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002683 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000982
C00000992
C00003794
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000982
C00003794
|
10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00000982
C00003794
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000982
C00003794
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000982
C00003794
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000982
C00003794
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000982
C00003794
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000982
C00003794
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000982
C00003794
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000982
C00003794
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000982
C00003794
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000982
C00003794
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000982
C00003794
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000982
C00003794
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000982
C00003794
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000982
C00003794
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000982
C00003794
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000982
C00003794
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000982
C00003794
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000982
C00003794
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000982
C00003794
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000982
C00003794
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000982
C00003794
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000982
C00003794
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000982
C00003794
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00000982
C00003794
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00000982
C00000992
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003794
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000982
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00000982
|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00000982
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000982
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000982
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000982
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00000982
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000992
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000992
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00000992
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00003794
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00003794
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00003794
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00003794
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00003794
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003794
|
891 | CCNB1, CCNB | cyclin B1 |
C00003794
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003794
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00003794
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00003794
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003794
|
9415 | FADS2, D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13 | fatty acid desaturase 2 (EC:1.14.19.-) |
C00003794
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00003794
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00003794
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00003794
|
3122 | HLA-DRA, HLA-DRA1, MLRW | major histocompatibility complex, class II, DR alpha |
C00003794
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00003794
|
3600 | IL15, IL-15 | interleukin 15 |
C00003794
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00003794
|
3554 | IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80 | interleukin 1 receptor, type I |
C00003794
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00003794
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00003794
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00000982
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003794
|
5335 | PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1 | phospholipase C, gamma 1 (EC:3.1.4.11) |
C00003794
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00003794
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00003794
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00003794
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003794
|
6309 | SC5D, ERG3, S5DES, SC5DL | sterol-C5-desaturase (EC:1.14.21.6) |
C00003794
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00003794
|
2810 | SFN, YWHAS | stratifin |
C00003794
|
6783 | SULT1E1, EST, EST-1, ST1E1, STE | sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) |
C00003794
|
29110 | TBK1, NAK, T2K | TANK-binding kinase 1 (EC:2.7.11.1) |
C00003794
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00003794
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00003794
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00003794
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00003794
|
7161 | TP73, P73 | tumor protein p73 |
C00003794
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00003794
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00003794
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00003794
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00003794
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#300018 | 46,xy sex reversal 2; srxy2 |
P51843
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#300200 | Adrenal hypoplasia, congenital; ahc |
P51843
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P47869
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#114500 | Colorectal cancer; crc |
P18054
P84022 |
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#614546 | Efavirenz, poor metabolism of |
P20813
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P37231 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#601665 | Obesity |
P37231
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P00734
P16109 |
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 |
P62158
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
P24864 (related) |
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) P24864 (related) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H00552 | Glycerol kinase deficiency (GKD) |
P51843
(related)
|
H00607 | 46,XY disorders of sex development (Disorders of gonadal development) |
P51843
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000647 | Amnesia |
C00000982
|
D001932 | Brain Neoplasms |
C00000982
|
D009202 | Cardiomyopathies |
C00000982
|
D056486 | Drug-Induced Liver Injury |
C00000982
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000982
|
D007674 | Kidney Diseases |
C00000982
|
D008106 | Liver Cirrhosis, Experimental |
C00000982
|
D008107 | Liver Diseases |
C00000982
|
D009369 | Neoplasms |
C00000982
|
D009374 | Neoplasms, Experimental |
C00000982
|
D000707 | Anaphylaxis |
C00003794
|
D003110 | Colonic Neoplasms |
C00003794
|
D007249 | Inflammation |
C00003794
|
D007680 | Kidney Neoplasms |
C00003794
|
D008175 | Lung Neoplasms |
C00003794
|
D011230 | Precancerous Conditions |
C00003794
|